PEOPLE - Sterotaxis makes appointment:
This article was originally published in Clinica
Executive Summary
Sterotaxis, a St Louis, Missouri firm that designs, manufactures and markets a cardiology instrument control system has appointed Kevin Shifrin as senior vice-president of global marketing and business development; and Magnus Holm as general manager for Europe. The company will leverage the international business experience of both executives. Mr Shifrin joins from C R Bard where he was vice-president, global marketing (peripheral vascular division). Dr Holm joins from Biosense Webster (treatment of cardiac arrhythmias) where he was vice-president for Europe Middle East and Africa.